Skip to main content

Advertisement

SpringerLink
Log in

Nanostructured Lipid Carriers Improve Skin Permeation and Chemical Stability of Idebenone

  • Research Article
  • Published:
AAPS PharmSciTech Aims and scope Submit manuscript

Abstract

Idebenone (IDB) is a synthetic antioxidant and analog of coenzyme Q10. The percutaneous permeation of IDB was investigated in guinea pig skin after application of different formulations. The enhancing effects of various formulations [nanostructured lipid carriers (NLCs), nanoemulsion (NE), or oil solution] on the permeation of IDB were evaluated using ex vivo guinea pig skins. Furthermore, stability of different formulations and in which chemical stability of IDB was determined during storage. Permeation experiments revealed that formulations varied in their ability to enhance the skin permeation of IDB. For NLC formulation, the cumulative amount of IDB in the epidermis, dermis, and acceptor medium of diffusion cells was approximately threefold more than NE or oil solution at the end of 24-h experiment. No significant difference between NE and oil solution was observed in the enhancement of penetration efficacy of IDB. Different formulations resulted in stability with different properties. NLC formulation revealed preferentially more stable than NE. The residual percentage of IDB loaded in NLCs, NE, and oil solution was 90.1%, 65.4%, and 51.3%, respectively, when stored at 40°C under 75% RH and 3,000 lx light conditions for 180 days. The results obtained here demonstrated that the abilities of NLCs to improve the chemical stability of IDB and enhance the skin permeation are much better than NE and oil solution. These suggest that NLCs containing IDB have significant potential use for skin care as an alternative topical formulation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

REFERENCES

  1. Mcdaniel DH, Neudecker BA, Dinardo JC, Lewis JA, Maibach H. Clinical efficacy assessment in photodamage skin of 0.5% and 1.0% idebenone. J Cosmet Dermatol. 2005;4:167–73.

    Article  PubMed  CAS  Google Scholar 

  2. Farris P. Idebenone, green tea, and Coffeeberry® extract: new and innovative antioxidants. Dermatol Ther. 2007;20:322–9.

    Article  PubMed  Google Scholar 

  3. McDaniel DH, Neudecker BA, DiNardo JC, Lewis JA, Maibach HI. Idebenone: a new antioxidant—Part I. Relative assessment of oxidative stress protection capacity compared to commonly known antioxidants. J Cosmet Dermatol. 2005;4:10–7.

    Article  PubMed  CAS  Google Scholar 

  4. Amorim CM, Couto AG, Netz DJA, de Freitas RA, Bresolin TMB. Antioxidant idebenone-loaded nanoparticles based on chitosan and N-carboxymethylchitosan. Nanomedicine. 2010;6:745–52.

    Article  CAS  Google Scholar 

  5. Palumbo M, Russo A, Cardile V, Renis M, Paolino D, Puglis G, Fresta M. Improved antioxidant effect of idebenone-loaded polyethyl-2-cyanoacrylate nanocapsules tested on human fibroblasts. Pharm Res. 2002;19:71–8.

    Article  PubMed  CAS  Google Scholar 

  6. Amidi M, Mastrobattista E, Jiskoot W, Hennink WH. Chitosan-based delivery systems for protein therapeutics and antigens. Adv Drug Deliv Rev. 2010;62:59–82.

    Article  PubMed  CAS  Google Scholar 

  7. Müller RH, Petersen RD, Hommoss A, Pardeike J. Nanostructured lipid carriers (NLC) in cosmetic dermal products. Adv Drug Deliv Rev. 2007;59:522–30.

    Article  PubMed  Google Scholar 

  8. Obeidat WM, Schwabe K, Müller RH, Keck CM. Preservation of nanostructured lipid carriers (NLC). Eur J Pharm Biopharm. 2010;76:56–67.

    Article  PubMed  CAS  Google Scholar 

  9. Mehnert W, Mäder K. Solid lipid nanoparticles: production, characterization and applications. Adv Drug Deliv Rev. 2001;47:165–96.

    Article  PubMed  CAS  Google Scholar 

  10. Chen CC, Tsai TH, Huang ZR, Fang JY. Effects of lipophilic emulsifiers on the oral administration of lovastatin from nanostructured lipid carriers: physicochemical characterization and pharmacokinetics. Eur J Pharm Biopharm. 2010;74:474–82.

    Article  PubMed  CAS  Google Scholar 

  11. Artuch R, Colomé C, Vilaseca MA, Aracil A, Pineda M. Monitoring of idebenone treatment in patients with Friedreich’s ataxia by high-pressure liquid chromatography with electrochemical detection. J Neurosci Meth. 2002;115:63–6.

    Article  CAS  Google Scholar 

  12. Fang JY, Fang CL, Liu CH, Su YH. Lipid nanoparticles as vehicles for topical psoralen delivery: solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC). Eur J Pharm Biopharm. 2008;70:633–40.

    Article  PubMed  CAS  Google Scholar 

  13. Gillet A, Compre P, Lecomte F, Hubert P, Ducat E, Evrard B, et al. Liposome surface charge influence on skin penetration behaviour. Int J Pharm. 2011;411:223–31.

    Article  PubMed  CAS  Google Scholar 

  14. Junyaprasert VB, Teeranachaideekul V, Souto EB, Boonme P, Müller RH. Q10-loaded NLC versus nanoemulsions: stability, rheology and in vitro skin permeation. Int J Pharm. 2009;377:207–14.

    Article  PubMed  CAS  Google Scholar 

  15. Driscoll D. Lipid injectable emulsions: pharmacopeial and safety issues. Pharm Res. 2006;23:1959–69.

    Article  PubMed  CAS  Google Scholar 

  16. Müller RH, Radtke M, Wissing SA. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv Drug Deliv Rev. 2002;54:131–55.

    Article  Google Scholar 

  17. Peltola S, Saarinen-Savolainen P. Microemulsions for topical delivery of estradiol. Int J Pharm. 2003;254:99–107.

    Article  PubMed  CAS  Google Scholar 

  18. Freitas C, Müller RH. Effect of light and temperature on zeta potential and physical stability in solid lipid nanoparticle (SLN™) dispersions. Int J Pharm. 1998;168:221–9.

    Article  CAS  Google Scholar 

  19. Pathak P, Nagarsenker M. Formulation and evaluation of lidocaine lipid nanosystems for demal delivery. AAPS PharmSciTech. 2009;10:985–92.

    Article  PubMed  CAS  Google Scholar 

  20. Tursilli R, Casolari A, Iannuccelli V, Scalia S. Enhancement of melatonin photostability by encapsulation in lipospheres. J Pharmaceut Biomed. 2006;40:910–4.

    Article  CAS  Google Scholar 

  21. Mordente A, Martorana GE, Minotti G, Giardina B. Antioxidant properties of 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4- benzoquinone (Idebenone). Chem Res Toxicol. 1998;11:54–63.

    Article  PubMed  CAS  Google Scholar 

  22. Alvarez-Roman R, Naik A, Kalia YN, Guy RH, Fessi H. Skin penetration and distribution of polymeric nanoparticles. J Control Release. 2004;99:53–62.

    Article  PubMed  CAS  Google Scholar 

  23. Rouse JG, Yang J, Ryman-Rasmussen JP, Barron AR, Monteiro-Riviere NA. Effects of mechanical flexion on the penetration of fullerene amino acid-derivatized peptide nanoparticles through skin. Nano Lett. 2007;7:155–60.

    Article  PubMed  CAS  Google Scholar 

  24. Singh P, Sihorkar V, Jaitely V, Kanaujia P, Vyas SP. Pilosebaceous unit: anatomical considerations and drug delivery opportunities. Ind J Pharmacol. 2000;32:269–81.

    CAS  Google Scholar 

  25. Lademann J, Richter H, Schanzer S, Knorr F, Meinke M, Sterry W, et al. Penetration and storage of particles in human skin: perspectives and safety aspects. Eur J Pharm Biopharm. 2011;77:465–8.

    Article  PubMed  CAS  Google Scholar 

  26. Toll R, Jacobi U, Richter H, Lademann J, Schaefer H, Blume-Peytavi U. Penetration profile of microspheres in follicular targeting of terminal hair follicles. J Invest Dermatol. 2004;123:168–76.

    Article  PubMed  CAS  Google Scholar 

  27. Lademann J, Richter H, Teichmann A, Otberg N, Blume-Peytavi U, Luengo J, et al. Nanoparticles—an efficient carrier for drug delivery into the hair follicles. Eur J Pharm Biopharm. 2007;66:159–64.

    Article  PubMed  CAS  Google Scholar 

  28. Nam SH, Ji XY, Park JS. Investigation of tacrolimus loaded nanostructured lipid carriers for topical drug delivery. Bull Korean Chem Soc. 2011;32:956–60.

    Article  CAS  Google Scholar 

  29. Nokhodchi A, Shokri J, Dashbolaghi A, Hassan-Zadeh D, Ghafourian T, Barzegar-Jalali M. The enhancement effect of surfactants on the penetration of lorazepam through rat skin. Int J Pharm. 2003;250:359–69.

    Article  PubMed  CAS  Google Scholar 

  30. Bos JD, Meinardi MMHM. The 500 Dalton rule for the skin penetration of chemical compounds and drugs. Exp Dermatol. 2000;9:165–9.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmaceutical Engineering, School of Chemical Engineering and Technology, Tianjin University, Education Ministry Key Laboratory of Systems Bioengineering, Tianjin, 300072, People’s Republic of China

    Bei Li & Zhi-Qiang Ge

Authors
  1. Bei Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zhi-Qiang Ge
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Zhi-Qiang Ge.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Li, B., Ge, ZQ. Nanostructured Lipid Carriers Improve Skin Permeation and Chemical Stability of Idebenone. AAPS PharmSciTech 13, 276–283 (2012). https://doi.org/10.1208/s12249-011-9746-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1208/s12249-011-9746-3

KEY WORDS

Search

Navigation